Inventor · disambiguated record
Ralf Huss
Also filed as: HUSS RALF
4 granted patents·12 pending applications·97 citations·filing 1999–2023
76Inventor score
Files withAPCETH GMBH & CO KG5HUSS RALF4JUNCTUCELL BIOMED MFG GMBH3NELSON PETER JON2JunctuCell Biomed1
Top patents by PatentIndex Score
16 records- 0186US7998472B2CD34 stem cell-related methods and compositionsAPCETH GMBH & CO KG·Filed 2008·Granted Aug 16, 2011·28 cites·7 claims
- 0281US6361997B1Genetically modified CD34-negative adherently growing stem cells and their use in gene therapyFiled 1999·Granted Mar 26, 2002·67 cites·2 claims
- 0375US11464806B2Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cellsJUNCTUCELL BIOMED MFG GMBH·Filed 2020·Granted Oct 11, 2022·2 cites·20 claims
- 0464US2023226222A1Genetically modified mesenchymal stem cells expressing alpha-1 antitrypsin (aat)JUNCTUCELL BIOMED MFG GMBH·Filed 2023·Application pending·0 cites
- 0556US2020282078A1Genetically modified mesenchymal stem cells expressing alpha-1 antitrypsin (aat)JunctuCell Biomed·Filed 2020·Application pending·0 cites
- 0649US2020289577A1Protection of the vascular endothelium from immunologically mediated cytotoxic reactions with human cd34-negative progenitor cellsJUNCTUCELL BIOMED MFG GMBH·Filed 2020·Application pending·0 cites
- 0748US2011268714A1CD34 Stem Cell-Related Methods and CompositionsAPCETH GMBH & CO KG·Filed 2011·Application pending·0 cites
- 0846US9255139B2Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer and skin lesionsHUSS RALF·Filed 2006·Granted Feb 9, 2016·0 cites·21 claims
- 0943US2016008401A1Protection of the vascular endothelium from immunologically mediated cytotoxic reactions with human cd34-negative progenitor cellsAPCETH GMBH & CO KG·Filed 2014·Application pending·0 cites
- 1040US2015238541A1Cd34 stem cell-related methods and compositionsHUSS RALF·Filed 2015·Application pending·0 cites
- 1140US2016136207A1Cd34 stem cell-related methods and compositionsHUSS RALF·Filed 2015·Application pending·0 cites
- 1240US2012208769A1Chemokine-Mucin Fusions Linked to Glycosylphosphatidylinositol (GPI)-Anchors in Tissue Regeneration and as Tumour Immune AdjuvantsNELSON PETER JON·Filed 2006·Application pending·0 cites
- 1340US2015238526A1Cd34 stem cell-related methods and compositionsHUSS RALF·Filed 2015·Application pending·0 cites
- 1440US2018000969A1Genetically modified mesenchymal stem cells expressing alpha-1 antitrypsin (aat)APCETH GMBH & CO KG·Filed 2016·Application pending·0 cites
- 1537US2016271234A1TISSUE INHIBITOR OF METALLOPROTEINASES (Timp) LINKED TO GLYCOSYLPHOSPHATIDYLINOSITOL (Gpi) - ANCHORS FOR TREATMENT OF CANCER AND SKIN LESIONSNELSON PETER JON·Filed 2016·Application pending·0 cites
- 1631US2017239297A1Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cellsAPCETH GMBH & CO KG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ralf Huss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →